Cyrus Karkaria
Corporate Officer/Principal bei LUPIN LIMITED
Profil
Cyrus Karkaria is currently the President-Biotechnology at Lupin Ltd.
He was previously the Vice President-BPS & Operations at CuraGen Corp.
Karkaria holds a doctorate degree from the University of Maryland, a graduate degree from the University of Mumbai, and a graduate degree from Harvard Medical School.
Aktive Positionen von Cyrus Karkaria
| Unternehmen | Position | Beginn |
|---|---|---|
| LUPIN LIMITED | Corporate Officer/Principal | 07.10.2011 |
Ehemalige bekannte Positionen von Cyrus Karkaria
| Unternehmen | Position | Ende |
|---|---|---|
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - |
Ausbildung von Cyrus Karkaria
| University of Maryland | Doctorate Degree |
| University of Mumbai | Graduate Degree |
| Harvard Medical School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LUPIN LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
